Search FHI 360

Start a New Search

Search within these results

NewsHIV preventionArticleResearch services

5 Results Found

News

Final results of FEM-PrEP HIV-prevention study indicate great attention to adherence will be required in PrEP programs

RESEARCH TRIANGLE PARK, NC — Results of the FHI 360 FEM-PrEP HIV-prevention trial reinforce the key role of adherence in HIV-prevention studies and the need to determine better approaches to support adherence in future pre-exposure prophylaxis (PrEP...
News

'Science' names HIV prevention trial as breakthrough of the year

RESEARCH TRIANGLE PARK, NC — Today, Science named the HIV Prevention Trials Network (HPTN) 052 study "Breakthrough of the Year." FHI 360 congratulates our HPTN 052 collaborating partners on this important achievement. This is the second year in a...
News

VOICE HIV prevention trial discontinues Tenofovir gel arm

RESEARCH TRIANGLE PARK, NC — The Microbicides Trials Network (MTN) announced today that it will discontinue testing tenofovir vaginal gel in the HIV prevention trial VOICE (Vaginal and Oral Interventions to Control the Epidemic). This decision came...
News

HPTN 043 Project Accept study published in the Lancet Infectious Diseases demonstrates that community mobilization boosts HIV testing rates in developing countries

The addition of community mobilization activities and support services to a mobile HIV counseling and testing program can greatly improve the rates of initial and repeat testing in remote rural communities, according to new research supported by the...
News

FHI 360 statement on the Heffron et al study and hormonal contraceptives and HIV risk

On October 4, 2011 The Lancet Infectious Diseases published an article by Renee Heffron and a group of researchers at the University of Washington. The study was conducted among nearly 3,800 HIV-serodiscordant couples (in which one partner is HIV...

You are here

Search FHI 360

Practice Areas

Services

Content Types

Expertise Areas

Countries

Article Types

Final results of FEM-PrEP HIV-prevention study indicate great attention to adherence will be required in PrEP programs

'Science' names HIV prevention trial as breakthrough of the year

VOICE HIV prevention trial discontinues Tenofovir gel arm

HPTN 043 Project Accept study published in the Lancet Infectious Diseases demonstrates that community mobilization boosts HIV testing rates in developing countries

FHI 360 statement on the Heffron et al study and hormonal contraceptives and HIV risk